LXRX Competitors & Alternatives
Compare Lexicon Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
LXRX
Main Stock$2.23
Tradestie Score
60
Market Cap
$512.39M
Revenue Growth
-0.8%
Analyst Upside
+66.8%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$342.58
|
$1.12B | - | 62 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$10.87
|
$1.09B | - | 54 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$12.92
|
$1.05B | 67.7 | 52 | Compare |
|
MDXG
MiMedx Group, Inc
|
$3.56
|
$1.01B | 17.8 | 58 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$7.43
|
$997.16M | - | 54 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$2.93
|
$996.55M | - | 48 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$74.92
|
$994.20M | - | 56 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.68
|
$993.46M | - | 53 | Compare |
|
IMNM
Immunome, Inc.
|
$20.88
|
$987.09M | - | 57 | Compare |
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$8.51
|
$952.74M | - | 55 | Compare |
More LXRX Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry